Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't think we have any signs for a buyout yet. Advaxis still struggle with cash problem. Ken Berlin still struggle to find a partner for AXAL and for HOT because of no data available yet for NEO and PSA. If Ken coudn't find a partner, another dilution is coming for sure by mid 2019.IMO
It was just example
New picture on advaxis twitter, majority employees are female
https://twitter.com/Advaxis
Merck, Bristol-Myers profits rise on cancer drug sales
where is news for Amgen cancer drug sales? they need it to catch up
https://finance.yahoo.com/news/merck-bristol-myers-profits-rise-cancer-drug-sales-144358661--finance.html
I hope this is true and will happen, but now every signs look like another Roseta Genomics story. IMO
Cat, how this thing works, can you explain? Let's say Amgen owns 80% outstanding shares and paid $2billion to buyout advaxis. Is that mean they only have to pay 20% of $2billion because they already own 80%? thank you!
I agree, 16 years company, 4 CEOs, you really don't know who to blame but I still expect one day when i woke up in the morning and i see the news Advaxis is acquired by somebody or even bankrupt. LOL
Dan was a PR guy with nothing but bull$hit. I would rather see some quiet period with some real news.
Always pay more money to buy good quality products. same thing with hire CEO. You get what you paid for.
Anybody from South Carolina Here? check your mega ball ticket, maybe you are the winner. LOL
do you see a deal for Axal coming? Why in the world he wants to do a reverse split if the company worth billions? I don't think he wants to reverse back to 6 millions shares outstanding.
What I see we might see some deals coming soon, that can get us back to $5.00. with new data in 2019, back to double digit is possible. who knows, maybe the whole bio sector is going up in 2019. also we may get bought out if strong data showed! JMHO
I will ask my 6 years old daughter to buy some, because she got lot of quarters in her piggy bank!
Merck's tepid STING data pressures Aduro Biotech, down 24% premarket
https://seekingalpha.com/news/3399155-mercks-tepid-sting-data-pressures-aduro-biotech-24-percent-premarket
Bacterial injections into tumors show early promise for treating cancer
https://www.sciencemag.org/news/2018/10/bacterial-injections-tumors-show-early-promise-treating-cancer
good to see the old warrant is gone!
UCLA Amgen Presentation, LM is important for Amgen!
Senior R&D leaders David Reese & Raymond Deshaies delivered keynotes on Amgen’s discovery research and translational science capabilities
Senior R&D leaders David Reese & Raymond Deshaies delivered keynotes on #Amgen’s discovery research and translational science capabilities today at #UCLABiomedicalLifeScienceInnovationDay2018 @UCLATDG pic.twitter.com/gg6FUllJ8d
— Amgen 🧪🔬🧬 (@Amgen) June 13, 2018
Be patient! you will get more than that! Somebody will acquire advaxis sooner or later. If Amgen not buying it, then they have to pay royalties to the new company!
I used to own a stock droped under a dollar, and sold at $37, i waited 5 years.
I will wait and take advaxis to the grave!
I still believe buyout at $25.00 is possible if NEO and HOT deliver positive data. It is all about science and technology now, cash is just part of the game!
This tiny biotech spun a quick $2 billion from $12 million
https://www.marketwatch.com/story/this-tiny-biotech-spun-a-quick-2-billion-from-12-million-2018-10-18?siteid=yhoof2&yptr=yahoo
After all those year of waiting, we must be patient with another 2-3 years IMO
same thing with AMRN!
The Shape of Drugs to Come
https://www.amgenscience.com/features/the-shape-of-drugs-to-come/
Anybody got $26 million dollars, you can buy advaxis and control the company and fire BOD and management!
Advaxis either killed by Amgen or Rescued!
Maybe during ASCO 2019
All we need is good positive data from NEO! then everything is set!
Amgen science updated website, seems ADXS-NEO is very important for them
https://www.amgenscience.com/features/amgens-growing-immunotherapy-arsenal/
https://www.amgenscience.com/features/the-shape-of-drugs-to-come/#modalities
https://www.amgenscience.com/items/listeria-based-immunotherapy/
Advaxis on the brink of ruin again! where it is heading this time compare last time?
A biotech firm, on the brink of ruin, resurrects itself via man — and microbe
https://www.statnews.com/2016/08/22/advaxis-amgen-cancer-listeria/
Now they can take HOT!
Seems like Advaxis science technology is dead! and nobody wants it now! Oh God! what a mess! Where is the good data?
Cancer Startup Allogene Makes Trading Debut as Largest Biotech to IPO Since 2009
https://finance.yahoo.com/news/cancer-startup-allogene-makes-trading-163531808.html
Agree! not much time left for advaxis, either win or bankrupt!
Advaxis either succeed or bankruptcy! Good positive data will lead to more deals and investment from BPs with cash. Negative data with low cash reserve going to lead this company to bankruptcy for sure with no doubt! We are not sure which direction ken will lead us to at this moment! Hope $60 million could save this company!
It seems to me Listeria Mono technology just not in favor to the BPs anymore! Advaxis has wasted so much time and money, missed good opportunity to get a product on market like AXAL. read below article, you know AXAL has no chance, it will be a dead trial soon! only hope left is NEO and HOT. IMO
Australia set to 'eliminate' cervical cancer by 2028
https://www.cnn.com/2018/10/03/health/australia-eliminating-cervical-cancer-intl/index.html
stock price dropped?
AMRN really on fire now! Two years ago was a dollar stock. If you got bullet, No worry about stock price. is Advaxis got enough bullet or out of bullet? hard to tell at this moment. we will see much clear picture first half of 2019. data,data,data are the key to open the doors for deals and money!
Guess what! I think J&J might acquire HOT construct all together!
According to Slide 19 of presentation, Bristol-Myer and Astra Zenecca are out!
Great call by Fbg about J&J with aduro!
All I know is Ken used to work at J&J for a period of long time! Shh!!!!!!!!!!!!!